Karyopharm Therapeutics (NASDAQ:KPTI) reported quarterly earnings results on February 12, 2026 that fell short of analyst expectations. The Healthcare company reported earnings…
Karyopharm Therapeutics (NASDAQ:KPTI) reported quarterly earnings results on February 12, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-2.23, missing the consensus estimate of $-2.10 by $0.13 per share. Revenue came in at $34.1M, beating the estimate of $33.2M.
Karyopharm Therapeutics's stock moved following the earnings release. The stock currently trades at $8.97 with a market capitalization of $59.5M.
Current market data
NASDAQ · KPTI
$2.03
Down: -$0.04 · -1.72%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
earnings ·
sec_filing ·
analyst ·
analyst ·
